APA (7th ed.) Citation

J, N., H, J., R, Z., R, G., W, X., P, Z., . . . L, L. (2026). Diosmetin overcomes resistance to cisplatin in ovarian cancer by suppressing the MAPK signaling pathway. Medical oncology (Northwood, London, England), 43(5), . https://doi.org/10.1007/s12032-026-03293-8

Chicago Style (17th ed.) Citation

J, Nie, Jiang H, Zhou R, Gong R, Xu W, Zhang P, Lu L, and Lyu L. "Diosmetin Overcomes Resistance to Cisplatin in Ovarian Cancer by Suppressing the MAPK Signaling Pathway." Medical Oncology (Northwood, London, England) 43, no. 5 (2026). https://doi.org/10.1007/s12032-026-03293-8.

MLA (9th ed.) Citation

J, Nie, et al. "Diosmetin Overcomes Resistance to Cisplatin in Ovarian Cancer by Suppressing the MAPK Signaling Pathway." Medical Oncology (Northwood, London, England), vol. 43, no. 5, 2026, https://doi.org/10.1007/s12032-026-03293-8.